ArticleBMC cancer2025

Safety and efficacy of systemic chemotherapy plus PD-1 inhibitor in combination with intravenous or intraperitoneal bevacizumab in gastric cancer with peritoneal metastasis.

Yuxi Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.